Galatea Kallergi
机构: Department of Biology, University of Patras
每年引用次数
引用次数
引用: 3,432
H-指数: 30
I10-指数 : 44
出版物: 107
Evaluation of Monocarboxylate Transporter 4 (MCT4) Expression and Its Prognostic Significance in Circulating Tumor Cells From Patients With Early Stage Non-Small-Cell Lung Cancer.
A Kotsakis , E Lianidou , V Georgoulias , Athina Markou
Frontiers in Cell and Developmental Biology 9 641978 -641978
1
2021
Abstract P2-01-03: Truncated HER2 receptor in circulating tumor cells (CTCs) of early and metastatic breast cancer patients
G Kallergi , D Nasias , M Papadaki , D Mavroudis
Cancer Research 72
2012
Abstract P2-01-07: Effect of first-line chemotherapy in the expression of stemness and epithelial-to-mesenchymal transition markers in circulating tumor cells of patients with metastatic breast cancer.
S Agelaki , MA Papadaki , G Kallergi , D Mavroudis
Cancer Research 72
2012
Abstract PD04-04: Cytokeratin-19 mRNA Positive Circulating Tumor Cells during Follow-Up of Patients with Early Breast Cancer: Prognostic Relevance for Late Relapse
ES Saloustros , M Perraki , S Apostolaki , E Politaki
Cancer Research 70
2010
P4-07-20: Apoptosis in Circulating Tumor Cells (CTCs) of Early and Metastatic Breast Cancer Patients.
G Kallergi , G Konstantinidis , M Papadaki , S Agelaki
Cancer Research 71
2011
P4-07-15: Insulin-Like Growth Factor Receptor I (IGFIR) Expression in Circulating Tumor Cells (CTCs) of Patients with Early and Metastatic Breast Cancer (BC).
M Spiliotaki , H Markomanolaki , M Kokotsaki , G Kallergi
Cancer Research 71
2011
Abstract P2-02-03: HER2 expression on circulating tumor cells before adjuvant chemotherapy and during follow-up in patients with HER2-negative early breast cancer
H Markomanolaki , D Mavroudis , G Kallergi , E-K Vetsika
Cancer Research 76
2016
Abstract P1-04-08: Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer
MA Papadaki , S Agelaki , G Kallergi , Z Zafeiriou
Cancer Research 73
2013
Abstract P1-04-12: Prognostic value of CTC detection by RT-PCR and the CellSearch system before first-line chemotherapy in metastatic breast cancer
S Agelaki , D Mavroudis , E Politaki , S Apostolaki
Cancer Research 73
2013
VEGF, VEGFR2 and HIF-1α expression in circulating tumor cells (CTCs) of breast cancer patients.
G Kallergi , S Agelaki , V Gannoukaraki , H Markomanolaki
Cancer Research 69 1028
2009
Purpose: Monocarboxylate transporter 4 (MCT4) can influence the amount of lactate in the tumor microenvironment and further control cancer cell proliferation, migration, and angiogenesis. We investigated for the first time the expression of MCT4 in circulating tumor cells (CTCs) derived from early stage Non-Small Cell Lung Cancer patients (NSCLC) and whether this is associated with clinical outcome.
Talib Hassan Ali , Athina Markou , A Markou , E Tzanikou
Liquid Biopsy
2022
Prognostic value of the detection of circulating tumor cells using a multimarker RT-PCR (CK19, mammaglobin A, HER2/neu) in early breast cancer
M Ignatiadis , G Kallergi , M Ntoulia , S Apostolaki
BREAST CANCER RESEARCH AND TREATMENT 106 S26 -S26
1
2007
CXCR4 pathways in CTCs: from bioinformatics to immunophenotype
G Kallergi , V Tsintari , S Sfakianakis , M Zervakis
Cancer Research 75 ( 15_Supplement) 1592 -1592
2
2015
Molecular basis of gynecological cancer
DA Spandidos , DN Dokianakis , G Kallergi , E Aggelakis
Annals of the New York Academy of Sciences 900 ( 1) 56 -64
42
2000
Vascular endothelial growth factor (VEGF) expression in CTCs of breast cancer patients.
G Kallergi , S Agelaki , V Giannoukaraki , H Markomanolaki
Cancer Research 68 ( 9_Supplement) 276 -276
1
2008
HER2 expression on circulating tumor cells before adjuvant chemotherapy and during follow-up in patients with HER2-negative early breast cancer
H Markomanolaki , D Mavroudis , G Kallergi , EK Vetsika
CANCER RESEARCH 76
2016
Evaluation of proliferation and apoptosis markers in circulating tumor cells (CTCs) of women with early breast cancer who are candidates for tumor dormancy
M Soiliotaki , H Markomanolaki , G Kallergi , MA Papadaki
EUROPEAN JOURNAL OF CANCER 49 S434 -S434
2013
FAK and PI-3K are activated in micrometastatic human breast cancer cells
G Kallergi , D Mavroudis , A Gravanis , V Georgoulias
FEBS JOURNAL 272 314 -314
2005
Epithelial-Mesenchymal Transition Markers Are Expressed in CTCS of Breast Cancer Patients
G Kallergi , MA Papadaki , S Agelaki , D Mavroudis
Annals of Oncology 20 56 -56
2
2009
Effect of first-line chemotherapy in the expression of stemness and epithelial-to-mesenchymal transition markers in circulating tumor cells of patients with metastatic breast cancer.
MA Papadaki , G Kallergi , D Mavroudis , V Georgoulias
CANCER RESEARCH 72
1
2012